To investigate the underlying mechanism by which DCP1B suppresses NSCLC, RNA sequencing was conducted after knocking down DCP1B in A549 cells, resulting in the identification of MAPK4 as a key downstream gene that modulates AKT activity. Here, DCP1B is linked to non-small cell lung carcinoma.